A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported in Q1 CY2025, with sales up 45.2% year on year to $12.73 billion.

LEBANON, Ind. (WISH) — Gov. Mike Braun and Eli Lilly officials broke ground Tuesday on one of the first major projects for the LEAP District. Company officials said the Lilly Medicine Foundry ...

Eli Lilly is investing more in its home state of Indiana, pumping up to $250 million more into an existing collaboration with ...

Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and ...

Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...

Trump's Department of Commerce is looking into what it calls national security threats from overseas drug manufacturing, and ...

Eli Lilly stock has been a big-time winner over ... Beyond research and development (R&D), one of the major expense items for pharmaceutical companies is the cost of raw materials for making ...

These developments may fuel Eli Lilly's projected annual revenue growth of 22.7% and possibly improve its profit margins despite potential challenges like pricing pressures and rising R&D costs.

Eli Lilly (LLY) is among the list of large-cap pharmaceutical ... Meanwhile, the moves are threatening to weaken Europe's R&D and manufacturing strength, prompting executives like AstraZeneca's ...

Eli Lilly (NYSE:LLY) experienced an 11% share price increase over the past month, largely influenced by the affirmation of a ...